Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. Macrophages are present in the living ecosystem of many types of cancer. Using digital imaging, bioinformatics, and machine learning techniques, research led by N2CR member, Dr Anand Jeyasekharan, discovered 6 different macrophage signatures (MacroSigs) that can help distinguish types of macrophages in normal lymph nodes and diffuse large B-cell lymphoma (DLBCL), a tumour arising from our lymph nodes. This groundbreaking discovery helps doctors understand the evolution of this disease and how some DLBCL tumours relapse after chemotherapy. 

Read more: https://www.nature.com/articles/s41467-024-46220-z

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

New Book by Prof Goh Boon Cher & A/Prof Wang Lingzhi

We are pleased to share that Prof. Goh Boon Cher and A/Prof. Wang Lingzhi have published a new edited volume …

Read More →
Research News

New Hope for Treating Drug-Resistant Leukaemia

Acute myeloid leukaemia (AML) is a fast-growing blood cancer that often becomes resistant to standard treatments. This resistance is linked …

Read More →
Research News

Prospective Evaluation of QPOP in Relapsed/ Refractory Non-Hodgkin’s Lymphoma

Treatment of relapsed/refractory non-Hodgkin’s lymphoma (R/R-NHL) remains one of the most difficult challenges in haematologic malignancies, with many patients exhausting …

Read More →